Characterisation of the spectrum of demyelinating disease in Western Australia

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 79, Issue 9, 2008, Pages 1022-1026

  Wu, J S ^a   Zhang, M N ^b   Carroll, W M ^a   Kermode, Allan G ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASIAN; AUSTRALIA; CEREBROSPINAL FLUID; CLINICAL FEATURE; DEMYELINATING DISEASE; DISEASE DURATION; EVOKED VISUAL RESPONSE; FOLLOW UP; IMAGING; LABORATORY TEST; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; OPTIC SPINAL MULTIPLE SCLEROSIS; POPULATION RESEARCH; PRIORITY JOURNAL; SPECTRUM;

EID: 50449090759     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2007.131177     Document Type: Article

References (24)

1. de Seze J, Lebrun C, Stojkovic T, et al. Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosis. Mult Scler 2003;9:521-5.
2. Kira J. Multiple sclerosis in the Japanese population. Lancet Neurol 2003;2:117-27.
3. Devic C. Myelite subaigue complique de nerrite optique. Bull Med 1894;35:18-30.
4. Wasay M, Khatri IA, Khealani B, et al. MS in Asian countries. Int MS J 2006;13:58-65.
5. Pittock SJ, Lennon VA, Krecke K, et al. Brain abnormalities in neuromyelitis optica. Arch Neurol 2006;63:390-6.
6. Walker RW, Keir G, Johnson MH, et al. A rapid method for detecting oligoclonal IgG in unconcentrated CSF, by agarose isoelectric focusing, transfer to cellulose nitrate and immunoperoxidase staining. J Neuroimmunol 1983;4:141-8.
7. Blumenhardt LD, Halliday AM. Hemisphere contributions to the composition of the pattern-evoked potential waveform. Exp Brain Res 1979;36:53-69.
8. Carroll W, Halliday A, Kriss A. Improvements in the accuracy of pattern evoked potentials in the diagnosis of visual pathway disease. Neuroophthalmology 1982;2:237-53.
9. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-31.
10. Compston A, Edan G, Goodkin D, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121-7.
11. Kira J, Kanai T, Nishimura Y, et al. Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann Neurol 1996;40:569-74.
12. Wingerchuk DM, Hogancamp WF, O'Brien PC, et al. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999;53:1107-14.
13. English D, de Wytt C, Maxwell IC, et al. The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart. Neurology 1988;36:980-6.
14. Simmons RD, Hall CA, Gleeson P, et al. Prevalence survey of multiple sclerosis in the Australian Capital Territory. Herpes 2001;8:60-3.
15. Mana P, Goodyear M, Chow AM, et al. Progressive increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: a 35-year study. J Autoimmunity 2003;21:339-51.
16. Chang KH, Lyu RK, Chen CM, et al. Clinical characteristics of multiple sclerosis in Taiwan: a cross-sectional study. Mult Scler 2006;12:501-6.
17. Eikelenboom M, Killestein J, Uitdehaag B, et al. Opticospinal multiple sclerosis: a pathogenetically distinct form? Mult Scler 2004;10:334-35.
18. Bot JC, Barkhof F, Polman CH, et al. Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination. Neurology 2004;62:226-33.
19. Chong HT, Ramli N, Lee KH, et al. Magnetic resonance imaging of Asians with multiple sclerosis was similar to that of the West. Can J Neurol Sci 2006;33:95-100.
20. Bergamaschi R, Tonietti S, Franciotta D, et al. Oligoclonal bands in Devic's neuromyelitis optica and multiple sclerosis: differences in repeated cerebrospinal fluid examinations. Mult Scler 2004;10:2-4.
21. Nakashima I, Fujihara K, Nagata T, et al. Oligoclonal IgG bands in Japanese multiple sclerosis patients. Tohoku J Exp Med 1999;169:259-65.
22. Chong HT, Kermode AG, Tan CT. The role of anti-aquaporin-4 antibody in Asian patients with multiple sclerosis: Confusions and controversies. Neurol Asia 2007;12:135-9.
23. Wu JS, Matsushita T, Carroll WM, et al. Low sensitivity of aquaporin-4 antibody in multiple sclerosis, longitudinally extensive spinal cord lesions and neuromyelitis optica in Australians. Neurol Asia 2007;12:149-50.
24. Galetta SL, Bennett J. Neuromyelitis optica is a variant of multiple sclerosis. Arch Neurol 2007;64:901-3.